TORRENT PHARMACEUTICALS
Back to Income Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹10,728 Cr | ₹9,620 Cr | ₹8,508 Cr | ₹8,005 Cr | ₹7,939 Cr |
What is the latest Revenue of TORRENT PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹10,728 Cr |
| Mar2024 | ₹9,620 Cr |
| Mar2023 | ₹8,508 Cr |
| Mar2022 | ₹8,005 Cr |
| Mar2021 | ₹7,939 Cr |
How is Revenue of TORRENT PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹10,728 Cr | 11.51 | |
| Mar2024 | ₹9,620 Cr | 13.07 | |
| Mar2023 | ₹8,508 Cr | 6.29 | |
| Mar2022 | ₹8,005 Cr | 0.82 | |
| Mar2021 | ₹7,939 Cr | - | |
Compare Revenue of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹145,349.6 Cr | -1.5% | 3.3% | 37.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,735.0 Cr | -0.6% | 10.3% | 4.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,312.0 Cr | 1.4% | 11% | 11.5% | Stock Analytics | |
| CIPLA | ₹107,205.0 Cr | -2.6% | 7.9% | -13.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,592.0 Cr | -3.2% | 2.7% | 10.6% | Stock Analytics | |
| MANKIND PHARMA | ₹99,384.3 Cr | 1.4% | 15.8% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -1.5% |
3.3% |
37.6% |
| SENSEX | -4.3% |
-2.6% |
-7.6% |
You may also like the below Video Courses